CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-07 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-09-07 | Finizio Robert G CEO | Sale | −92,000 | $6.22 | $572K | 18,393,559 |
| 2018-09-07 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 1,288,910 | ||
| 2018-09-06 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-09-06 | Finizio Robert G CEO | Sale | −92,000 | $6.25 | $575K | 18,393,559 |
| 2018-09-06 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 1,380,910 | ||
| 2018-08-23 | Milligan John C.K. IV President/Secretary | Gift | −434,814 | 0 | ||
| 2018-08-23 | Milligan John C.K. IV President/Secretary | Gift | +434,814 | 434,814 | ||
| 2018-08-21 | Thompson Tommy G Director | Purchase | +4,000 | $5.53 | $22K | 683,500 |
| 2018-07-02 | Thompson Tommy G Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-07-02 | SEGAL NICHOLAS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | Russell Angus C. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | MUSING JULES A. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | LaPenta Robert V Jr Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | Collins Cooper C. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | CARROLL J MARTIN Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-02 | Barlow Jane F Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-04-17 | Barlow Jane F Director | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-03-15 | Finizio Robert G CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +440,000 | 440,000 | ||
| 2018-03-15 | Krassan Mitchell Chief Strategy Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +170,000 | 170,000 |
Page 23 of 24 · 463 trades